Advanced searches left 3/3

Enthesitis - Crossref

Summarized by Plex Scholar
Last Updated: 24 January 2023

* If you want to update the article please login/register

Achilles enthesitis on physical examination leads to worse outcomes after 2 years of follow up in patients with ankylosing spondylitis from REGISPONSER-AS registry

Enthesitis is one of the most common peripheral musculoskeletal manifestations in patients with axial spondyloarthritis. After 2 years of follow-up in patients with ankylosing spondylitis spondylitis, the aim of this research was to investigate the effects of Achillesâu2019 tendon enthesitis found at baseline during physical examination on the outcome measures. To determine the relationship between Achilles enthesitis at baseline and baseline patient-reported outcome data, linear regression models adjusted for age, body mass index, and anti-TNF intake were developed and tested. During physical examination at the baseline study visit, 46 patients had Achilles' u2019 tendon enthesitis, while physical examination revealed Achilles u2019 tendon enthesitis. Patients with and without Achilles enthesitis were respectively 15. 9% and 31. 5 percent after two years of follow-up, respectively.

Source link: https://doi.org/10.1186/s13075-023-02988-x


The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development

Both psoriasis and psoriatic arthritis are present in subcutaneous enthesopathy. The enthusesopathy in PsA was found to be u2018inflammatoryu2019 or vascular phenotype, contrary to that found in psoriasis. Methods 100 patients with a mean age of 46. 3 years and 23 healthy controls from two centres were included. Psoriasis patients were more likely to report a vascular phenotype, with elevated inflammation-related enthesopathy scores than HC compared to HC. Psoriasis patients and HC had higher ultrasound enthesopathy scores than those with psoriasis patients and HC. PsA patients had higher PD scores than psoriasis patients when symptomatic entheses were excluded. Conclusions This report shows that the ultrasound findings of subsitis in psoriasis differ from that of subcutaneous enthritisis in PsA, with PsA patients experiencing more PD.

Source link: https://doi.org/10.1136/annrheumdis-2012-201617


Complexity of enthesitis and new bone formation in ankylosing spondylitis: current understanding of the immunopathology and therapeutic approaches

ABSTRACT STRONG spondyloarthritis treatments, including tumour necrosis factor and interleukin-17 inhibitors, are now available in ankylosing spondylitis, a segment of SpA. The increased level of TNF in SpA patients' joint tissue was found in comparison to those of rheumatoid arthritis patients, which may promote TNF-driven osteo-proliferative changes in AS. AS immunopathology uses a combination of immune cells, both natural and adoptive immune cells, to orchestrate type 3 immunity.

Source link: https://doi.org/10.1093/mr/roab057


Enthesitis in Psoriatic Arthritis, the Sonographic Perspective

Purpose of Review (Psoriatic arthritis) The aim of this essay is to give an overview of the ultrasound findings focusing on enthesitis in psoriatic arthritis. Both u201cclassicalu201d and u201cfunctionalu201d entheses are able to detect pathological changes in both u201d and u201cfunctionalu201d entheses, which are able to detect pathologic changes in both u201d and u201d entheses. Summary U. S. has the capability to be the first-line approach to enthesitis diagnosis.

Source link: https://doi.org/10.1007/s11926-021-01039-1


Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial

Background information in patients with enthesitis-related arthritis and juvenile psoriatic arthritis are currently unobtainable. This trial was conducted to determine the effectiveness and safety of secukinumab in patients with active ERA and JPsA with inadequate responses to conventional therapy. Patients with TP2 immediately began an open-label secukinumab TP3 therapy that lasted up to week 104. With secukinumab versus placebo, the study met its primary end point and revealed a statistically significant longer time to disease flare in TP2 for ERA and JPsA. Overall, the JIA population's total incidence rates for total patients were 290. 7/100 PY for adverse outcomes and 8. 2/100 PY for major adverse events. Conclusions Secukinumab was found to have a longer time to disease outbreak in children with ERA and JPsA with a consistent safety profile including adult signs of psoriatic arthritis and axial spondyloarthritis.

Source link: https://doi.org/10.1136/ard-2022-222849


Tietze’s syndrome presenting as enthesitis diagnosed by ultrasound: A case report

We describe a case of isolated enthesitis in the sternocostal joint of a 42-year-old male patient whose medical history resulted in the diagnosis of TS. A 42-year-old male Japanese man suffered with chronic anterior chest wall pains. The rt. 3STCJ's hypoechoic thickening and power Doppler signal was found in the anterior radiate sternocostal ligament with mild synovial hypertrophy. During neovascularization, the United States also depicted cortical bone erosion at the sternum. TS can be caused by Enthesitis.

Source link: https://doi.org/10.1093/mrcr/rxac022


Dysregulation of micro-RNAs involved in TLR pathway in peripheral blood mononuclear cells and synovial fluid mononuclear cells of patients with enthesitis related arthritis form of juvenile idiopathic arthritis (HUM3P.254)

Abstract Toll like receptor pathway plays a significant role in inflammatory arthritis. In PBMC and SFMC of patients with ERA, we investigated expression of miR-146a, miR-155, miR-21, miR-210, and miR-26a. RNA was isolated from PBMC & SFMC of ERA patients and PBMC of controls RNA samples. Mean disease onset age was 10. 3Y, and disease duration was 6Y. In PBMC of patients and controls, miR-146a, miR-155, miR-210, and miR-26a, no linguistic difference was apparent, but miR-21 was elevated in patients. In SFMC, they tested aninflammatory site specific expression, comparing SFMC and PBMC showed downregulation of miR146a and the enforcement of miR-155, miR-21, and miR-210. Expression of miR-26a did not reflect any improvement. In mononuclear cells of patients with ERA-JIA, particularly at the chronic inflammation site, there is dysregulation of miRNAs that regulate TLR pathway.

Source link: https://doi.org/10.4049/jimmunol.194.supp.121.14


Evaluation of the measurement of tendon and ligament thicknesses and the presence of enthesitis in lower extremities in female patients with acne vulgaris: a randomized controlled trial

Patients with AV have no studies that have invasive the presence of enthesitis and lower extremity tendons and ligament thicknesses in patients with AV. In patients with AV, they need to determine the presence of enthesitis and muscle thickness in lower extremities, as well as the tendon and ligament thicknesses. Material and Method: Thirty patients with a AV diagnosis were included as well as 18 healthy participants. Acne severity was determined with the Global Acne Grading System. In patients with AV p. s. patients with AV p. m. , Proximal patellar ligaments, distal patellar ligaments, Achilles tendons, and plantar fascias thicknesses were all elevated in dominant and non-dominant legs, respectively.

Source link: https://doi.org/10.47582/jompac.1206740


Evaluation of the agreement between the ACR 1990 fibromyalgia tender points and an enthesitis score in patients with axial spondyloarthritis

Abstract Objectives: Coexistence of FM in patients with axial spondyloarthritis is a challenge in the diagnosis of enthesitis in patients with axial spondyloarthritis due to a potential similarity between the tender points due to enthesitis and those of FM. Objective: To determine the connection between the MASES enthesitis score and the ACR 1990 criteria in patients with axSpA, the aim was to determine the compatibility. Patients had axSpA diagnosis, according to their rheumatologist, and there was a warning to start a TNF blocker. According to the FirST, the intraclass correlation coefficient between the MASES and the ACR 1990 TPs is also stratified by the presence/absence of a concomitant FM. ACR 1990 TP was 5. 4, and mean MASES was 4. 2. Both scores had 0. 6 [95% CI] and 0. 7 [95% CI] for patients with and without FM, respectively.

Source link: https://doi.org/10.1093/rheumatology/keac683


A Systematic Review of the Inclusion of Non-Inflammatory Ultrasonographic Enthesopathy Findings in Enthesitis Scoring Indices

Ultrasound has revolutionized the diagnosis and treatment of patients with inflammatory rheumatic disorders. Several enthesitis scoring devices that use ultrasound to determine entheseal involvement have been created. This systematic analysis identified ultrasound scoring methodologies that have been used to measure enthositis and what key factors determine the score. However, some of the scoring methods, including enthesophytes, may be seen in non-inflammatory conditions, and others, including erosions, may not necessarily indicate active inflammatory disease. This report highlights the need for a more comprehensive ultrasound enthesopathy scoring system.

Source link: https://doi.org/10.3390/diagnostics11040669

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions